awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q53684267-E252F165-920C-4BA4-92E8-4A0357D57FE6
Q53684267-E252F165-920C-4BA4-92E8-4A0357D57FE6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53684267-E252F165-920C-4BA4-92E8-4A0357D57FE6
Exposure-response analysis of alectinib in crizotinib-resistant ALK-positive non-small cell lung cancer.
P2860
Q53684267-E252F165-920C-4BA4-92E8-4A0357D57FE6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53684267-E252F165-920C-4BA4-92E8-4A0357D57FE6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
98c9d3065bc2a9ef182edc5a6353a1bcedf26c89
P2860
Absorption, distribution, metabolism and excretion (ADME) of the ALK inhibitor alectinib: results from an absolute bioavailability and mass balance study in healthy subjects.